Protein misfolding and the pathogenesis of ABCA4-associated retinal degenerations

Ning Zhang1, Yaroslav Tsybovsky1, Alexander V Kolesnikov2

  • 1Department of Pharmacology and Cleveland Center for Membrane and Structural Biology and.

Human Molecular Genetics
|February 26, 2015
PubMed

Insights

The L541P;A1038V (PV) mutation in the ABCA4 gene causes severe retinal degeneration. Mouse models with this mutation rapidly degrade the misfolded protein, leading to minimal photoreceptor damage, unlike in humans.

Area of Science:

  • Genetics
  • Molecular Biology
  • Ophthalmology

Background:

  • Mutations in the ABCA4 gene are a primary cause of inherited retinal degeneration.
  • Current mouse models typically involve gene knockouts, not missense mutations common in human disease.
  • The complex allele L541P;A1038V (PV) is a significant cause of human ABCA4-related retinal disease.

Purpose of the Study:

  • To investigate the functional consequences of the PV missense mutation in ABCA4.
  • To compare the effects of the PV mutation in human cells and in a novel knock-in mouse model.
  • To understand the in vivo impact of misfolded ABCA4 protein on retinal degeneration.

Main Methods:

  • Heterologous expression of mutant ABCA4 proteins in mammalian cells.
  • Biochemical assays to measure ATPase activity.
  • Electron microscopy to assess protein structure.
  • Generation and analysis of Abca4(PV/PV) knock-in mice.
  • RNA sequencing of retinal and RPE tissues.

Main Results:

  • The PV mutation significantly reduced ABCA4 ATPase activity and caused protein misfolding in vitro.
  • Abca4(PV/PV) mice exhibited minimal mutant ABCA4 protein in the retina due to rapid degradation.
  • Despite lipofuscin accumulation, Abca4(PV/PV) mice showed no significant retinal degeneration up to 12 months.
  • Gene expression changes in Abca4(PV/PV) mice were mild compared to controls.

Conclusions:

  • Rapid degradation of misfolded ABCA4 protein in mice limits photoreceptor degeneration.
  • Significant differences exist in the unfolded protein response between murine and human photoreceptors.
  • Therapeutic strategies targeting the unfolded protein response may benefit patients with ABCA4 mutations.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
13.2K
Amyloid Fibrils03:03

Amyloid Fibrils

7.0K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
5.7K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K